The AMPK inhibitor overcomes the paradoxical effect of RAF inhibitors through blocking phospho-Ser-621 in the C terminus of CRAF

The Journal of Biological Chemistry
Jimin YuanJiancheng Hu

Abstract

The dimerization-driven paradoxical activation of RAF proto-oncogene Ser/Thr kinase (RAF) is the predominant cause of drug resistance and toxicity in cancer therapies with RAF inhibitors. The scaffold protein 14-3-3, which binds to the RAF C terminus, is essential for RAF activation under physiological conditions, but the molecular basis is unclear. Here we investigated whether and how 14-3-3 regulates the dimerization-driven transactivation of the RAF isoform CRAF by RAF inhibitors and affects drug resistance and toxicity by virtue of the dominant role of CRAF in these processes. We demonstrated that 14-3-3 enhances the dimerization-driven transactivation of CRAF by stabilizing CRAF dimers. Further, we identified AMP-activated protein kinase (AMPK) and CRAF itself as two putative kinases that redundantly phosphorylate CRAF's C terminus and thereby control its association with 14-3-3. Next, we determined whether the combinatory inhibition of AMPK and CRAF could overcome the paradoxical effect of RAF inhibitors. We found that the AMPK inhibitor (AMPKi) not only blocked the RAF inhibitor-driven paradoxical activation of ERK signaling and cellular overgrowth in Ras-mutated cancer cells by blocking phosphorylation of Ser-621 in CRA...Continue Reading

References

Oct 1, 1996·Molecular and Cellular Biology·H MischakW Kolch
Jun 3, 2000·Annual Review of Pharmacology and Toxicology·H FuS C Masters
Mar 18, 2003·Cellular Signalling·Huira ChongKun-Liang Guan
Mar 24, 2004·Cell·Paul T C WanUNKNOWN Cancer Genome Project
Nov 3, 2004·Nature Reviews. Molecular Cell Biology·Claudia WellbrockRichard Marais
Mar 2, 2006·Molecular and Cellular Biology·Linda K RushworthWalter Kolch
Nov 28, 2006·Biochimica Et Biophysica Acta·James A McCubreyRichard A Franklin
May 15, 2007·Oncogene·A S DhillonW Kolch
Dec 26, 2007·Molecular Immunology·Jiancheng HuRaul M Torres
Sep 4, 2009·Nature·Thanashan RajakulendranMarc Therrien
Oct 26, 2010·Trends in Biochemical Sciences·Susan S Taylor, Alexandr P Kornev
Mar 29, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jiancheng HuAndrey S Shaw
Jul 23, 2011·Genes & Cancer·David MatallanasWalter Kolch
Jul 19, 2013·Biochemical Society Transactions·Susan S TaylorAlexandr Kornev
Feb 26, 2014·Molecular and Cellular Biology·Andrey S ShawSusan S Taylor
Jun 4, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jiancheng HuRaul M Torres
Jun 18, 2014·FEBS Letters·Botond CsehManuela Baccarini
Jun 25, 2014·Nature Reviews. Cancer·Matthew HolderfieldMartin McMahon
Oct 29, 2014·Molecular and Cellular Biology·Jiancheng HuAndrey S Shaw
Apr 25, 2015·Nature Reviews. Molecular Cell Biology·Hugo Lavoie, Marc Therrien
May 23, 2015·Cell·Enrico DesideriManuela Baccarini

❮ Previous
Next ❯

Methods Mentioned

BETA
co-immunoprecipitation
immunoprecipitation
transfection
Immunoprecipitations

Software Mentioned

GraphPad Prism
ImageJ
GraphPad
GraphPad InStat

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.